Am J Epidemiol

1. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
   Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening.
   Am J Epidemiol. 2026 Feb 27:kwag040. doi: 10.1093.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. PAWLOSKI KR, Nelson JA, Sevilimedu V, Le T, et al
   Predictors of Satisfaction with Breasts and Psychosocial Well-Being After Nipple-Sparing Mastectomy.
   Ann Surg Oncol. 2026;33:7193-7205.
   

   >> Share

   
   
3. JAEN DM, Adwer LM, Lanoux-Nguyen AS, Hon HH, et al
   How to Find the Nerve: Nipple Nerve Allograft Reconstruction for Sensory Restoration in Nipple-Sparing Mastectomy.
   Ann Surg Oncol. 2026;33:7247-7248.
   

   >> Share

   
   
4. MYERS SP, Gokun Y, Slover B, Davenport SP, et al
   Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age.
   Ann Surg Oncol. 2026;33:7216-7228.
   

   >> Share

   
   
5. LATTIMORE CM, Wanis KN, Kuerer HM, Hunt KK, et al
   ASO Visual Abstract: Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?
   Ann Surg Oncol. 2026 Jul 5. doi: 10.1245/s10434-026-20181.
   

   >> Share

   
   
6. CHEN JH, Peregrin-Alvarez I, Warneke CL, McKenzie LJ, et al
   Oncologic Safety of Preoperative Controlled Ovarian Stimulation for Fertility Preservation Among Women with Estrogen Receptor Positive Breast Cancer.
   Ann Surg Oncol. 2026 Jul 5. doi: 10.1245/s10434-026-20156.
   

   >> Share

   
   
7. KORSHOLM RHR, Kroman N, Tvedskov TF, Munck F, et al
   Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection in Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study.
   Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20072.
   

   >> Share

   
   
8. CAMPBELL EJ, Doughty L, Sakellariou S, Trafford P, et al
   Potential Impact of Sentinel Lymph Node Biopsy Omission on Adjuvant Treatment Decisions in Low-Risk Breast Cancer: A Regional Multicenter 775 Patient Review of Current Practice in the United Kingdom.
   Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20134.
   

   >> Share

   
   
9. LATTIMORE CM, Wanis KN, Kuerer HM, Hunt KK, et al
   Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?
   Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20141.
   

   >> Share

   
   
10. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and Axilla.
    Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20152.
    

    >> Share

    
    
11. AMBURN T, Gemignani ML
    ASO Author Reflections: The Role of Lymphovascular Invasion in Early-Stage Breast Cancer Identified After the Omission of Sentinel Lymph Node Biopsy.
    Ann Surg Oncol. 2026 Jul 7. doi: 10.1245/s10434-026-20177.
    

    >> Share

    
    
12. AMBURN T, Sporn M, Arthurs L, Marsh C, et al
    Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20135.
    

    >> Share

    
    
13. ZHANG L, Birla S, Tang SX, Galloway OW, et al
    Impact of Total and Positive Lymph Node Count on Recurrence in Young Women with Node-Positive Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20154.
    

    >> Share

    
    
14. JAEN DM, Dougherty CE, Helseth KA, Harwell PA, et al
    Nodal Pathologic Response After Neoadjuvant Systemic Therapy in Clinically Advanced Node-Positive (cN2 and cN3) Breast Cancer.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20149.
    

    >> Share

    
    
15. MATHEWS AL, Fan B, Pesce C, Kopkash K, et al
    Practice Patterns and Overall Survival for Octogenarians with Triple Negative Breast Cancer Treated at Accredited Cancer Centers in the USA.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20133.
    

    >> Share

    
    
16. GERVAIS C, Brouillette K, Benzouak T, Altuntur SK, et al
    ASO Author Reflections: Rethinking Surgical Timing Benchmarks in Upfront Breast Cancer Surgery.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20166.
    

    >> Share

    
    
17. MATHEWS AL, Fan B, Pesce C, Kopkash K, et al
    ASO Visual Abstract: Practice Patterns and Overall Survival for Octogenarians with Triple-Negative Breast Cancer Treated at Accredited Cancer Centers in the United States.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20178.
    

    >> Share

    
    
18. SARS C, Chen EY, Johansson ALV, Dickman PW, et al
    Socioeconomic Status and Survival in Sarcomas of the Breast: Nationwide Cohort Study.
    Ann Surg Oncol. 2026;33:7181-7192.
    

    >> Share

    
    

    
    BMC Cancer

19. DONG F, He S, Wu B, Li J, et al
    The impact of orthogonal image-guided frequency on positioning error correction and dose in postoperative radiotherapy for breast cancer.
    BMC Cancer. 2026 Jul 6. doi: 10.1186/s12885-026-16443.
    

    >> Share

    
    
20. ESAN DT, Onabanjo OD, Rasaq NO, Ramos CG, et al
    Illness perception of breast cancer among patients receiving treatment in a university teaching hospital, South-west Nigeria: a qualitative phenomenological study.
    BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16527.
    

    >> Share

    
    
21. CHUN K, Tran-Dang MP, Cornett P, Tashombe C, et al
    Outreach to Native Hawaiian and Pacific Islander communities to increase breast cancer screening and clinical trial awareness.
    BMC Cancer. 2026 Jul 8. doi: 10.1186/s12885-026-16493.
    

    >> Share

    
    
22. BHATTACHARYYA S, Thomas JV, Prasad A, Deep A, et al
    Genomic landscape of triple-negative breast cancer in South Asian populations: a systematic review.
    BMC Cancer. 2026 Jul 6. doi: 10.1186/s12885-026-16455.
    

    >> Share

    
    
23. CHEN Y, Wang D, Li L, Lin T, et al
    Non-linear association between body mass index and port-related thrombosis in breast cancer patients: a retrospective cohort study.
    BMC Cancer. 2026 Jul 4. doi: 10.1186/s12885-026-16488.
    

    >> Share

    
    

    
    Breast Cancer

24. NARUI K, Miyahara K, Uemura Y, Yamada A, et al
    Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
    Breast Cancer. 2026 Jul 6. doi: 10.1007/s12282-026-01889.
    

    >> Share

    
    
25. LIM AR, Jung SP, Kim K, Choi HJ, et al
    Functional characterization of BRCA2 variants of uncertain significance identified in Korean breast cancer patients.
    Breast Cancer. 2026 Jul 4. doi: 10.1007/s12282-026-01886.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

26. YI G, Deng L, Su L, Jie H, et al
    Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.
    Breast Cancer (Dove Med Press). 2026;18:617698.
    

    >> Share

    
    

    
    Breast Cancer Res

27. WANG R, Li X, Zhu H, Li L, et al
    Predicting sentinel lymph node metastasis in breast cancer using an interpretable machine learning approach based on multi-domain clinical features.
    Breast Cancer Res. 2026 Jul 7. doi: 10.1186/s13058-026-02329.
    

    >> Share

    
    
28. YAN C, Cui F, Liu C, Ling R, et al
    LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase.
    Breast Cancer Res. 2026 Jul 8. doi: 10.1186/s13058-026-02343.
    

    >> Share

    
    
29. NIMBALKAR VP, V P S, Dash A, Jothikumar M, et al
    Postpartum breast cancer as a distinct oncologic entity: linking physiological tissue remodelling to tumor biology and clinical translation.
    Breast Cancer Res. 2026 Jul 8. doi: 10.1186/s13058-026-02341.
    

    >> Share

    
    
30. SARTORI GP, Ramalho S, da Silva LR, Telles GD, et al
    H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.
    Breast Cancer Res. 2026 Jul 8. doi: 10.1186/s13058-026-02334.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

31. FEDELE P, Rizzo A, Landriscina M, Stucci LS, et al
    Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study.
    Breast Cancer Res Treat. 2026;218:8.
    

    >> Share

    
    
32. COMEAUX JG, Gutierrez N, Ricker CN, Nie Q, et al
    Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk.
    Breast Cancer Res Treat. 2026;218:6.
    

    >> Share

    
    
33. MARTINS-BRANCO D, Lobo-Martins S, Aftimos P, Pereira B, et al
    EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.
    Breast Cancer Res Treat. 2026;218:7.
    

    >> Share

    
    
34. LUNDORFF CMB, Njor SH, Madsen SL, Jorgensen SF, et al
    Socioeconomic variation in adherence to follow-up after an abnormal screening mammogram in the Danish breast cancer screening program.
    Breast Cancer Res Treat. 2026;218:5.
    

    >> Share

    
    
35. HUANG S, Westvold SJ, Soulos PR, Lewin JM, et al
    Tumor characteristics associated with tomosynthesis versus digital mammography in older women with screen-detected breast cancer.
    Breast Cancer Res Treat. 2026;218:4.
    

    >> Share

    
    
36. ZHANG X, Barrios A, Higgins L, Markowski T, et al
    mRNA and protein expression of fetal insulin receptor in breast cancer cell lines and tissues.
    Breast Cancer Res Treat. 2026;218:2.
    

    >> Share

    
    
37. MASUDA N, Saji S, Kojima Y, Kitada M, et al
    Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.
    Breast Cancer Res Treat. 2026;218:3.
    

    >> Share

    
    
38. RAFII S, Al-Shamsi HO, Brufsky A
    SERENA-6 and the regulatory limits of radiologic progression in modern oncology.
    Breast Cancer Res Treat. 2026;218:1.
    

    >> Share

    
    

    
    Breast J

39. PELLEGRINO M, Ioppolo F, Ranalli M, Miccini M, et al
    Complications, Functional Recovery, and Quality of Life in Breast Cancer Patients Undergoing Axillary Surgery.
    Breast J. 2026;2026:e1469203.
    

    >> Share

    
    
40. SANGI NASAB LAHIJAN A, Abdollahi S, Miri SR, Azizi-Tabesh G, et al
    Circulating Plasma Circular RNAs hsa_circ_0001785 and hsa_circ_0079876 as Promising Noninvasive Diagnostic Biomarkers for Breast Cancer: A Case-Control Study.
    Breast J. 2026;2026:e8008795.
    

    >> Share

    
    

    
    Cancer

41. ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
    Cancer. 2026;132:e70462.
    

    >> Share

    
    
42. DI COSIMO S, Appierto V, Reduzzi C, De Cecco L, et al
    Circulating tumor DNA in early breast cancer: Evidence, challenges, next steps.
    Cancer. 2026;132:e70521.
    

    >> Share

    
    
43. GENTRY AL, Sereika SM, Erickson KI, McCall MK, et al
    The relationship of neighborhood socioeconomic disadvantage and pretreatment cancer-related cognitive impairment in women with breast cancer: A post hoc analysis of a randomized controlled trial.
    Cancer. 2026;132:e70506.
    

    >> Share

    
    

    
    Cancer Lett

44. WANG X, Hua R, Riquelme MA, Zhang J, et al
    Mechano-activation of Osteocytic Connexin Hemichannels Prime Microenvironment in Suppressing Breast Cancer Bone Metastasis.
    Cancer Lett. 2026 Jul 9:218722. doi: 10.1016/j.canlet.2026.218722.
    

    >> Share

    
    

    
    Cancer Res

45. TARRAGO-CELADA J, Mahmood AS, Panina Y, Lalwani S, et al
    Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis.
    Cancer Res. 2026 Jul 7. doi: 10.1158/0008-5472.CAN-25-3883.
    

    >> Share

    
    
46. CLEAR KY, Arnone AA, Tsai YT, Wilson AS, et al
    Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk.
    Cancer Res. 2026 Jul 9. doi: 10.1158/0008-5472.CAN-25-2087.
    

    >> Share

    
    

    
    Clin Breast Cancer

47. BASTA A, Lien K, Ni G, Sun W, et al
    A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2026;26:7-13.
    

    >> Share

    
    
48. MCDOUGALL R, Shi Y, Robbins J, Hsu C, et al
    COVID-19 as a Catalyst for Ultra-Hypofractionated Radiotherapy in Early Breast Cancer: Trends, Predictors, and Estimated Cost Savings.
    Clin Breast Cancer. 2026;26:1-6.
    

    >> Share

    
    
49. BINTALIB SO, Yeo SS, Loh HYM, Gambre AS, et al
    Reducing Clip Migration in Mammographic-Guided Vacuum Assisted Biopsy With Direct Insertion of the UltraCor Twirl Clip Marker: A Quality Improvement Project.
    Clin Breast Cancer. 2026;26:46-55.
    

    >> Share

    
    

    
    Eur Radiol

50. KIM HJ, Chae EY, Eom HJ, Choi WJ, et al
    Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis.
    Eur Radiol. 2026;36:6682-6696.
    

    >> Share

    
    
51. SANTONOCITO A, Bechyna S, Clauser P, Helbich TH, et al
    Impact of background parenchymal enhancement on the diagnosis of enhancing lesions in breast MRI: a systematic approach.
    Eur Radiol. 2026;36:6669-6678.
    

    >> Share

    
    
52. ZHANG Z, Elabeid J, Ali T, Pantleo J, et al
    From pixels to pathology: how artificial intelligence mammographic risk scores capture tumor biology through imaging.
    Eur Radiol. 2026;36:6730-6740.
    

    >> Share

    
    

    
    Histopathology

53. QUINN C, Tan PH, Allison KH, Brogi E, et al
    World Health Organization classification of tumours of the breast 6th edition 2026.
    Histopathology. 2026;89:199-218.
    

    >> Share

    
    
54. LAOKULRATH N, Lau HY, Gudi M, Rakha E, et al
    Attenuated to absent myoepithelial cells in benign and non-invasive breast lesions-potential diagnostic pitfalls.
    Histopathology. 2026;89:219-239.
    

    >> Share

    
    
55. KOONG JET, Shafique A, Md Nasir ND, Han A, et al
    Artificial intelligence modelling in grading breast phyllodes tumours.
    Histopathology. 2026;89:383-389.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

56. FACONDO G, Prisco A, Reverberi C, Festa E, et al
    Incidence and Predictors of Fat Necrosis After Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer: Results From a Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2026 Jul 9:S0360-3016(26)03946.
    

    >> Share

    
    

    
    J Clin Oncol

57. YAN J, Xiong W, Cai H
    Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.
    J Clin Oncol. 2026 Jul 7:JCO2600539. doi: 10.1200/JCO-26-00539.
    

    >> Share

    
    
58. TUNG NM, Li T, Garber JE
    Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.
    J Clin Oncol. 2026 Jul 7:JCO2600940. doi: 10.1200/JCO-26-00940.
    

    >> Share

    
    

    
    J Natl Cancer Inst

59. CASAGRANDE CC, Deardorff RL, Zhai W, Small BJ, et al
    Longitudinal effects of comorbidities on brain structure and cognition in older breast cancer survivors.
    J Natl Cancer Inst. 2026 Jul 3:djag219. doi: 10.1093.
    

    >> Share

    
    
60. MINAMI CA, Jager LR, Lorentzen EH, Shadyab AH, et al
    Worsening frailty and declining quality of life in older survivors of non-metastatic breast cancer.
    J Natl Cancer Inst. 2026 Jul 3:djag218. doi: 10.1093.
    

    >> Share

    
    
61. SHEN P, Chen X, Wang C, Xu F, et al
    RE?Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
    J Natl Cancer Inst. 2026 Jul 3:djag187. doi: 10.1093.
    

    >> Share

    
    
62. LEE CI, Lowry KP, Elmore JG
    Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness.
    J Natl Cancer Inst. 2026 Jul 6:djag121. doi: 10.1093.
    

    >> Share

    
    
63. SHAH Z, Lei L, Thakur R, Buradkar A, et al
    Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.
    J Natl Cancer Inst. 2026 Jul 7:djag223. doi: 10.1093.
    

    >> Share

    
    
64. BUONAIUTO R, Pagliuca M, Longobardi A, Cataldo ML, et al
    Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2026 Jul 10:djag220. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

65. WILLIAMS T, Li MX, Fine KS, Melnick BA, et al
    Racial Differences in Breast Cancer Treatment and Information Access.
    J Surg Oncol. 2026 Jul 5. doi: 10.1002/jso.70304.
    

    >> Share

    
    

    
    Nature

66. 
    Breast cancer driver genes found by screening chromosome aberrations in vivo.
    Nature. 2026 Jul 8. doi: 10.1038/d41586-026-02014.
    

    >> Share

    
    
67. AL-ZAHRANI KN, Langille ER, Nurtanto J, Obersterescu A, et al
    Aneuploidy selects for the acquisition of driver genes in breast cancer.
    Nature. 2026 Jul 8. doi: 10.1038/s41586-026-10752.
    

    >> Share

    
    

    
    NPJ Breast Cancer

68. DIELEMAN S, Bruggeling C, Le PD, Hillege LE, et al
    Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response.
    NPJ Breast Cancer. 2026 Jul 6. doi: 10.1038/s41523-026-01004.
    

    >> Share

    
    
69. TORR B, Mansour L, Fierheller CT, Hamill M, et al
    Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway.
    NPJ Breast Cancer. 2026 Jul 9. doi: 10.1038/s41523-026-01000.
    

    >> Share

    
    

    
    Oncogene

70. YI Y, Wang C, Yu X
    Repositioning osteocytes as integrative regulators of breast cancer bone metastasis.
    Oncogene. 2026 Jul 9. doi: 10.1038/s41388-026-03887.
    

    >> Share

    
    

    
    PLoS One

71. GRUNFELD AM, Bokros M, Paz K, Bilbao D, et al
    Amyloid-bodies in the evolution of malignancies.
    PLoS One. 2026;21:e0353464.
    

    >> Share

    
    
72. HOVDA T, Sober S, Padrik P, Kruuv-Kao K, et al
    A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.
    PLoS One. 2026;21:e0345431.
    

    >> Share

    
    
73. SONG SG, Cho SI, Sim T, Shin S, et al
    Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
    PLoS One. 2026;21:e0352979.
    

    >> Share

    
    
74. NGUYEN V, Pham TV, Dinh TH, Tran DN, et al
    Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam.
    PLoS One. 2026;21:e0352690.
    

    >> Share

    
    
75. 
    Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    PLoS One. 2026;21:e0352946.
    

    >> Share

    
    

    
    Radiologia (Engl Ed)

76. ARENAS RIVERA EN, Maiques JM, Alcantara R, Roman M, et al
    AI WAVEMAR: Design of an artificial intelligence model for detecting suspicious findings in screening mammography.
    Radiologia (Engl Ed). 2026;68:501741.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share